[ET Net News Agency, 21 January 2022] JOINN Laboratories (China) Co. Ltd. (06127) said
the group is expecting to record a net profit attributable to equity shareholders of the
company of approximately RMB542.79 million to RMB574.29 million for the year ended 31
December 2021, an increase of approximately 72.3% to 82.3% as compared with RMB315.01
million as recorded in the corresponding period in 2020.
It was due to (1) an increase in the group's revenue; and (2) a non-recurring profit
after deduction of income tax of approximately RMB27 million due to various factors
including government subsidies, income from trading of financial assets and foreign
exchange settlement of proceeds raised from the global offering of the shares of the
company on the Stock Exchange, which represented an increase of approximately RMB4 million
as compared with the corresponding period in 2020. (RC)